HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity

Benay Eksi, Daniel Finke, Synje Michel, Jannek Brauer, Markus B. Heckmann, Mohsen Valadan, Leonard M. Schanze, Vighnesh Sunder, Kevin Steimel, Jürgen Burhenne, Timon Seeger, Hugo A. Katus, Norbert Frey, Johannes Backs, Lorenz H. Lehmann

Open source

DOI
10.1038/s41467-026-77428-w
Published
2026-09-04
Container
Nature Communications
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-77428-w,
  title = {HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity},
  author = {Benay Eksi and Daniel Finke and Synje Michel and Jannek Brauer and Markus B. Heckmann and Mohsen Valadan and Leonard M. Schanze and Vighnesh Sunder and Kevin Steimel and Jürgen Burhenne and Timon Seeger and Hugo A. Katus and Norbert Frey and Johannes Backs and Lorenz H. Lehmann},
  year = {2026},
  journal = {Nature Communications},
  doi = {10.1038/s41467-026-77428-w},
  url = {https://doi.org/10.1038/s41467-026-77428-w}
}

RIS

TY  - JOUR
TI  - HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity
AU  - Benay Eksi
AU  - Daniel Finke
AU  - Synje Michel
AU  - Jannek Brauer
AU  - Markus B. Heckmann
AU  - Mohsen Valadan
AU  - Leonard M. Schanze
AU  - Vighnesh Sunder
AU  - Kevin Steimel
AU  - Jürgen Burhenne
AU  - Timon Seeger
AU  - Hugo A. Katus
AU  - Norbert Frey
AU  - Johannes Backs
AU  - Lorenz H. Lehmann
PY  - 2026
JO  - Nature Communications
DO  - 10.1038/s41467-026-77428-w
UR  - https://doi.org/10.1038/s41467-026-77428-w
ER  - 

APA

Eksi, B., Finke, D., Michel, S., Brauer, J., Heckmann, M. B., Valadan, M., Schanze, L. M., Sunder, V., Steimel, K., Burhenne, J., Seeger, T., Katus, H. A., Frey, N., Backs, J., & Lehmann, L. H. (2026). HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity. Nature Communications. https://doi.org/10.1038/s41467-026-77428-w

Source records